Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

SpainBack to Spain

Clinical trials in Burjassot

28 clinical trials in Burjassot, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Burjassot at a glance
28
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

28 trials in Burjassot

Open in trial search

Cardiovascular disorder+1

Recruiting

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Graves' disease

Recruiting

Phase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Age-related macular degeneration

Recruiting

A Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyebiotech Limited

Dry age-related macular degeneration

Recruiting

FWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Novartis Pharma AG

Eye disorder

Recruiting

A Study Testing How Well Faricimab Works in Patients with Subretinal Hyperreflective Material Associated with Neovascular Membranes in the Eye

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Faricimab
  • Sponsor:Asociacion Instituto De Investigacion Sanitaria Biobizkaia

Neovascular age-related macular degeneration

Recruiting

Study of Faricimab Treatment Given Every 24 Weeks in Patients with Age-Related Macular Degeneration

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Faricimab
  • Sponsor:F. Hoffmann-La Roche AG

Dry age-related macular degeneration+1

Recruiting

Study of Pozelimab and Cemdisiran for Adults with Geographic Atrophy from Age-Related Macular Degeneration

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cemdisiran
  • Sponsor:Regeneron Pharmaceuticals Inc.

Neovascular age-related macular degeneration

Recruiting

Study on Long-Term Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a Port Delivery System

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ranibizumab
  • Sponsor:F. Hoffmann-La Roche AG

Dry age-related macular degeneration

Recruiting

Study on Long-term Safety of JNJ-81201887 for Patients with Geographic Atrophy Due to Age-related Macular Degeneration

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Janssen Cilag International

Dermatitis atopic

Not yet recruiting

Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Adults with Moderate to Severe Atopic Dermatitis (Phase 2 Study)

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Stargardt's disease

Not yet recruiting

Phase 3 Study of Gildeuretinol Acetate (ALK‑001) to Assess Safety and Efficacy in Slowing Progression of Stargardt Disease in Adults

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years

Dry age-related macular degeneration

Not yet recruiting

A study to evaluate the safety and effectiveness of ADX-038 in adults with geographic atrophy caused by age-related macular degeneration.

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:ADX-038
  • Sponsor:Adarx Pharmaceuticals Inc.

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Burjassot

What the registry says about research in the country

01 Ophthalmology Research

Groundbreaking studies focusing on age-related macular degeneration and its variants, including both wet and dry forms. Research encompasses innovative delivery systems and new therapeutic approaches for treating retinal conditions.

  • Geographic Atrophy Treatment
  • Neovascular AMD Therapies
  • Diabetic Macular Edema

Multiple trials are evaluating long-term safety and efficacy of intravitreal treatments and novel drug delivery systems.

02 Dermatology Studies

Clinical investigations centered on treating atopic dermatitis and cutaneous conditions. Research focuses on evaluating new therapeutic agents for moderate to severe cases.

  • Cutaneous Lupus Erythematosus
  • Moderate-to-Severe Atopic Dermatitis
  • Long-term Treatment Solutions

Studies include both adult and adolescent participants, examining various dosing regimens and treatment combinations.

03 Pediatric Medicine

Dedicated research programs examining conditions affecting young patients, including myopia progression and migraine management in pediatric populations.

  • Pediatric Migraine Treatment
  • Myopia Progression Control
  • Vision Care Solutions

Trials focus on safe, effective treatments specifically designed for younger patients.

Back to SpainAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.